Webinar, page-56

Gee such a mixed bag of opinions! Yes the saliva test didn’t work out as hoped (not one I had much hope for but they’re still working on alternatives) but the positives on the Eugeni outweighed that imo, all ducks in a row to make big sales as soon as we get TGA approval. And the update on the battery was positively stellar! Strong prospect of imminent sales and better to chase revenue from there rather than spending years trying to develop the next gen. Get some $$ while its there. Not expecting the share price to rocket on this update…but I wouldn’t be selling either.